Preschool children (ie, those aged 5 years or younger) with wheeze consume a
disproportionately high amount of health-care resources compared with older children and …

Despite the availability of several formulations of inhaled corticosteroids (ICS) and delivery
devices for treatment of childhood asthma and despite the development of evidence-based …

Asthma often starts before six years of age. However, there remains uncertainty as to when
and how a preschool-age child with symptoms suggestive of asthma can be diagnosed with …

Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt.
Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch …

Although montelukast is generally well tolerated, postmarketing studies have reported
serious neuropsychiatric adverse drug reactions (ADRs) leading to a United States Food …

Background Asthma is a common long‐term breathing condition that affects approximately
300 million people worldwide. People with asthma may experience short‐term worsening of …

Background Inhaled corticosteroids (ICS) are the first‐line treatment for children with
persistent asthma. Their potential for growth suppression remains a matter of concern for …

Heterogeneity of asthma and difficulty in achieving optimal control are the major challenges
in the management of asthma. To help attain the best possible clinical outcomes in patients …

Background Long-term inhaled corticosteroids (ICS) may reduce growth velocity and final
height of children with asthma. We aimed to evaluate the association between ICS use of> …

Inhaled corticosteroids (ICS) are common medications, used in respiratory medicine for
controlling conditions such as asthma and other obstructive airway diseases. The systemic …